ASBPW / Aspire Biopharma Holdings, Inc. - Equity Warrant - Net Long/Short Value

Aspire Biopharma Holdings, Inc. - Equity Warrant

ASBPW / Aspire Biopharma Holdings, Inc. - Equity Warrant - Net Long/Short Value
Esta página fornece as avaliações líquidas longas/curtas para cada participação institucional relatada através de arquivamentos 13F ou NPORT. Para calcular o valor líquido longo/curto, somamos o valor de patrimônio ao valor da opção de compra e subtraímos o valor da opção de venda. Fundos que relatam posições emprestadas curtas apresentarão valores de patrimônio como negativos. Posições líquidas longas terão números positivos na coluna líquido longo/curto, e posições líquidas curtas terão valores negativos nessa coluna.
Proprietário Valor de Patrimônio
($1000)
Valor de Compra
($1000)
Valor de Venda
($1000)
Líquido Longo/Curto
($1000)
Polar Asset Management Partners Inc.
Jpmorgan Chase & Co
Whitebox Advisors Llc
Crossingbridge Advisors, LLC
Verition Fund Management LLC
Antara Capital LP
Wolverine Asset Management Llc
Periscope Capital Inc.
Investors Research Corp
Blue Owl Capital Holdings LP
Aristeia Capital Llc
Limestone Investment Advisors LP
Flow Traders U.s. Llc
Picton Mahoney Asset Management
Susquehanna International Group, Llp
Barclays Plc
Toronto Dominion Bank
Clear Street Group Inc.
Advisor Group Holdings, Inc.
Beacon Pointe Advisors, LLC
Context Capital Management, LLC
Athos Capital Ltd
Millennium Management Llc
D. E. Shaw & Co., Inc.
Adage Capital Partners Gp, L.l.c.
Mint Tower Capital Management B.V.
OMERS ADMINISTRATION Corp
Saba Capital Management, L.P.
VR Advisory Services Ltd
Linden Advisors Lp
Highbridge Capital Management Llc
Sculptor Capital LP
LMR Partners LLP
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista